RU99108789A - INHIBITOR OF SUBEPITELIAL POGGENITS - Google Patents

INHIBITOR OF SUBEPITELIAL POGGENITS

Info

Publication number
RU99108789A
RU99108789A RU99108789/14A RU99108789A RU99108789A RU 99108789 A RU99108789 A RU 99108789A RU 99108789/14 A RU99108789/14 A RU 99108789/14A RU 99108789 A RU99108789 A RU 99108789A RU 99108789 A RU99108789 A RU 99108789A
Authority
RU
Russia
Prior art keywords
inhibitor
nebula
subepithelial
cornea
dimethoxycinnamoyl
Prior art date
Application number
RU99108789/14A
Other languages
Russian (ru)
Inventor
Еити ИВАКИ
Икуо ТОБАРИ
Сусуму ОКАМОТО
Татсуро САКАИ
Original Assignee
Киссеи Фармасьютикал Ко., Лтд.
Нихон Тенганиаку Ко., Лтд.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Киссеи Фармасьютикал Ко., Лтд., Нихон Тенганиаку Ко., Лтд. filed Critical Киссеи Фармасьютикал Ко., Лтд.
Publication of RU99108789A publication Critical patent/RU99108789A/en

Links

Claims (5)

1. Игибитор субэпителиального помутнения (туманности) роговицы, включающий в качестве активного ингредиента N-(3,4-диметоксициннамоил)антраниловую кислоту формулы
Figure 00000001

и ее фармацевтически приемлемую соль.1. Inhibitor of subepithelial turbidity (nebula) of the cornea, including as active ingredient N- (3,4-dimethoxycinnamoyl) anthranilic acid of the formula
Figure 00000001

and its pharmaceutically acceptable salt. 2. Ингибитор субэпителиального помутнения (туманности) роговицы по п. 1, стандартная форма которого представляет собой глазные капли или мази. 2. Inhibitor of subepithelial turbidity (nebula) of the cornea according to claim 1, the standard form of which is eye drops or ointment. 3. Способ профилактики или лечения субэпителиального помутнения (туманности) роговицы, включающий введение N-(3,4-диметоксициннамоил)антраниловой кислоты формулы:
Figure 00000002

или ее фармацевтически приемлемой соли.3. A method for the prevention or treatment of subepithelial turbidity (nebula) of the cornea, including the introduction of N- (3,4-dimethoxycinnamoyl) anthranilic acid of the formula:
Figure 00000002

or its pharmaceutically acceptable salt. 4. Применение N-(3,4-диметоксициннамоил)антраниловой кислоты формулы:
Figure 00000003

или ее фармацевтически приемлемой соли для получения фармацевтической композиции, предназначенной для профилактики или лечения субэпителиального помутнения (туманности) роговицы.4. The use of N- (3,4-dimethoxycinnamoyl) anthranilic acid of the formula:
Figure 00000003

or its pharmaceutically acceptable salt to obtain a pharmaceutical composition intended for the prevention or treatment of subepithelial opacities (nebula) of the cornea. 5. Применение N-(3,4-диметоксициннамоил)антраниловой кислоты формулы:
Figure 00000004

или ее фармацевтически приемлемой соли в качестве ингибитора субэпителиального помутнения (туманности) роговицы.5. The use of N- (3,4-dimethoxycinnamoyl) anthranilic acid of the formula:
Figure 00000004

or its pharmaceutically acceptable salt as an inhibitor of the subepithelial clouding (nebula) of the cornea.
RU99108789/14A 1996-09-28 1997-09-24 INHIBITOR OF SUBEPITELIAL POGGENITS RU99108789A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP8/292222 1996-09-28

Publications (1)

Publication Number Publication Date
RU99108789A true RU99108789A (en) 2001-02-10

Family

ID=

Similar Documents

Publication Publication Date Title
RU94041223A (en) Agent for motoneuron disease treatment
EA200100524A1 (en) AMIDES OF ANTRANILIC ACID AND THEIR APPLICATION AS MEDICINES
RU93056633A (en) ANTIALLERGIC COMPOSITION FOR TREATMENT OF EYES OR NOSE
EP0391002A3 (en) Pharmaceutical compositions containing n-(3,4-dimethoxycinnamoyl) anthranilic acid
DE60316779D1 (en) THIADIAZOLYLPIPERAZINE DERIVATIVES SUITABLE FOR THE TREATMENT OF BZW. PREVENTION OF PAIN
EA199901015A1 (en) 4 "-SUBSTITUTED DERIVATIVES 9-DEOXO-9A-A3A-9A-HOMOERITROMYCIN A
RU95122135A (en) COMBINATION FOR PREVENTION AND TREATMENT OF AIDS, PHARMACEUTICAL COMPOSITION ON ITS BASIS
RU2002117649A (en) PHARMACEUTICAL COMPOSITIONS CONTAINING ZOLMITRIPTAN
TW225536B (en)
EA200000176A1 (en) APPLICATION OF PHYSIOLOGICAL ACCEPTABLE COMPOUNDS, SALTS AND COMPLEXES OF VANADIUM
WO2002102743A3 (en) DEUTERATED N-SUBSTITUTED AND α-SUBSTITUTED DIPHENYLALKOXY ACETIC ACID AMINO ALKYL ESTERS AND MEDICAMENTS CONTAINING THESE COMPOUNDS
RU98103388A (en) (R) -5-BROM-N- (1-ETHYL-4-Methylhexagidro-1H-1,4-Diazepin-6-IL) -2-METHOXI-6-M COMPOSITION CONTAINING THE SPECIFIED CONNECTION
RU95109157A (en) ANTIHIPPERGLICEMICALLY EFFECTIVE PHARMACEUTICAL COMPOSITION
IE780217L (en) 1,3,5-triazine-2,6-dione derivatives
ATE404192T1 (en) USE OF NEFIRACETAM TO TREAT POSTISCHEMIC NEURODEGENERATION
RU94011321A (en) METHOD OF PREVENTION AND TREATMENT OF SKIN DISEASES
RU99108789A (en) INHIBITOR OF SUBEPITELIAL POGGENITS
EA199801015A1 (en) DERIVATIVES OF PIPERIDINOXIC ACID AND THEIR APPLICATION IN THE TREATMENT OF THROMBOTIC DISORDERS
EP0950409A4 (en) Subepithelial turbidity inhibitor
RU2009127858A (en) PHARMACEUTICAL COMPOSITION, INCLUDING ALISKIREN AND AVOSENTAN
RU2004129767A (en) Quinoline Derivatives
NO940064L (en) Eye preparation on polyacrylic acid basis
RU2000125000A (en) COMPOSITION FOR ANTISEPTIC TREATMENT OF HAND SKIN AND OPERATION FIELD
RU2002106483A (en) A new class of physiologically active glycoproteins
RU92016559A (en) DIALCOXY-PYRIDINYLBENZIMIDAZOLE DERIVATIVES, PHARMACEUTICAL COMPOSITION, METHOD FOR INHIBITING OR TREATMENT, METHOD FOR PRODUCING THEM, USE AND INTERMEDIATE COMPOUNDS